Page last updated: 2024-08-17

vincristine and bpr0l075

vincristine has been researched along with bpr0l075 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, JY; Chang, YL; Chen, CP; Chen, CT; Chen, LT; Hsieh, HP; Kuo, CC; Lee, SJ; Liou, JP; Pan, WY1
Chang, CY; Chang, JY; Chiang, YK; Coumar, MS; Hsieh, HP; Kuo, CC; Lai, MJ; Liou, JP; Reddy, GR; Tan, UK; Wu, SY; Yeh, JY1

Other Studies

2 other study(ies) available for vincristine and bpr0l075

ArticleYear
BPR0L075, a novel synthetic indole compound with antimitotic activity in human cancer cells, exerts effective antitumoral activity in vivo.
    Cancer research, 2004, Jul-01, Volume: 64, Issue:13

    Topics: Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Division; Cell Line, Tumor; Colchicine; Drug Screening Assays, Antitumor; G2 Phase; Humans; Indoles; KB Cells; Male; Mice; Mice, Nude; Microtubules; Mitochondria; Mitosis; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tubulin; Tubulin Modulators; Xenograft Model Antitumor Assays

2004
Synthesis and structure-activity relationships of 2-amino-1-aroylnaphthalene and 2-hydroxy-1-aroylnaphthalenes as potent antitubulin agents.
    Journal of medicinal chemistry, 2008, Dec-25, Volume: 51, Issue:24

    Topics: Anisoles; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Humans; Indoles; Inhibitory Concentration 50; Models, Chemical; Naphthalenes; Neoplasms; Structure-Activity Relationship; Tubulin; Tubulin Modulators

2008